Episodes
198
Latest episode
Jun 2026
Language
EN
Host of Making Money on FOX Business and Wall Street expert, Charles Payne, wants to help you start making money right now. On the limited series "Charles Payne’s Unstoppable Prosperity Podcast," he is sharing his financial wisdom from decades of massive success in the stock market and giving you the tools you need to start investing. A few FOX Business friends help tell his story and discuss maintaining financial prosperity, and achieving your financial dreams.
Charles is joined by Eva Ados, COO of ER Shares, to discuss the high-stakes potential of a SpaceX IPO and the company’s infrastructure moat, why they are blocking Wall Street hedge funds from hijacking the XOVR ETF, and the strong fundamentals of companies like Anduril and Astera Labs. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Charles is joined by Essex Investment Management Co-CEO, Nancy Prial, to discuss the broadening of the AI trade into industrials and power grids, the top stock picks for the housing and healthcare sectors, and the impact of the small-cap market's robust earnings and revenue growth. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Charles is joined by Jim Worden, CIO of Wealth Consulting Group, to talk about why this "top-heavy" market still has room to run, the long-term potential of powering the AI boom, and why he’s sticking with Palantir and Adobe even when other investors are starting to doubt them. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Charles is joined by Mario Veneroso, partner at Kingsview Wealth Management, to discuss his "secret sauce" formula for identifying high-growth stocks, Amazon’s aggressive move into the global logistics market, and why Palantir remains a long-term play despite current negative sentiment. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Charles discusses the rebound potential in defense and healthcare stocks while highlighting long-term contrarian value. He is joined by Kiana Danial, CEO of Invest Diva, to explore shifting market dynamics including the replenishment of missile stockpiles, the appeal of dividend-paying stocks, and the role of Bitcoin as financial insurance. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Charles is joined by Brendan Ahern, Chief Investment Officer at KraneShares, to discuss the massive revenue efficiency of private AI firms like Anthropic and OpenAI, Micron’s explosive growth as a key player in AI infrastructure, and a potential geopolitical breakthrough regarding Iran reopening the Strait of Hormuz. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Charles is joined by Stockbrokers.com Director of Investor Research, Jessica Inskip, to discuss the security vulnerabilities exposed by AI models like Mythos, the top stock picks for the AI and cybersecurity sectors, and the impact of the EU AI Act taking effect in August 2026. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Charles is joined by Mario Veneroso, Kingsview Partners Wealth Manager, to discuss why improving fundamentals and technical charts signal a bullish market turn, the phenomenal growth of AI-driven plays like FTAI and CrowdStrike, and why UPS presents an attractive opportunity for investors through cost-cutting and high dividends. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Charles is joined by Rebecca Walser, Walser Wealth Management President, to discuss the resilience of the stock market despite a major geopolitical conflict, why the massive demand for AI memory and networking makes Micron and Jabil strategic "buys," and how Coherent's partnership with NVIDIA positions it as a key player in the AI backbone. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Charles is joined by Hilary Kramer, Greentech Research Investment Analyst and portfolio manager, to discuss the resilience of the stock market , why the massive demand for AI fiber optics makes Lumentum a "buy" with 50% upside , and how Finium Therapeutics uses mushroom research to help veterans. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Claim this listing to keep it up to date, reach guests who want to pitch you, and manage bookings with Guestify.
Claim this listing
